Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 114, Issue , 2014, Pages 111-120

  Hao, Jifu ^a   Wang, Xiaodan ^a   Bi, Yanping ^a   Teng, Yufang ^a   Wang, Jianzhu ^a   Li, Fei ^a   Li, Qiankui ^a   Zhang, Jimei ^a   Guo, Fengguang ^a   Liu, Jiyong ^b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Central composite design; Ocular drug delivery; Resina Draconis; Solid lipid nanoparticle; Thermosensitive hydrogels

Indexed keywords

AUTOMOBILE MANUFACTURE; DRUG DELIVERY; EMULSIFICATION; NANOPARTICLES; RESINS;

CENTRAL COMPOSITE DESIGNS; OCULAR DRUG DELIVERY; RESINA DRACONIS; SOLID LIPID NANOPARTICLE (SLN); THERMO-SENSITIVE HYDROGEL;

HYDROGELS;

DRUG CARRIER; HERBACEOUS AGENT; RESINA DRACONIS; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; CORNEA PERFORATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; GELATION; HEAT SENSITIVITY; HYDROGEL; IN VITRO STUDY; INTRAOCULAR DRUG ADMINISTRATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

CENTRAL COMPOSITE DESIGN; OCULAR DRUG DELIVERY; RESINA DRACONIS; SOLID LIPID NANOPARTICLE; THERMOSENSITIVE HYDROGELS;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHICKENS; CHORIOALLANTOIC MEMBRANE; CORNEA; DRUG DELIVERY SYSTEMS; HYDROGEL; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; RABBITS; SOFTWARE; STATISTICS AS TOPIC; SURFACE PROPERTIES; TEMPERATURE;

EID: 84886867429     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.09.059     Document Type: Article

References (32)

1. Lee V.H., Robinson J.R. Topical ocular drug delivery: recent developments and future challenges. J. Ocular Pharmacol. 1986, 2:67-108.
2. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev. 2005, 57:1595-1639.
3. Gupta S., Samanta M.K., Raichur A.M. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPS PharmSciTech 2010, 11:322-335.
4. Gaudana R., Jwala J., Boddu S.H., Mitra A.K. Recent perspectives in ocular drug delivery. Pharm. Res. 2009, 26:1197-1216.
5. Rupenthal I.D., Green C.R., Alany R.G. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int. J. Pharm. 2011, 411:69-77.
6. Gan L., Wang J., Jiang M., Bartlett H., Ouyang D., Eperjesi F., Liu J., Gan Y. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov. Today 2013, 18:290-297.
7. Sahoo S.K., Dilnawaz F., Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov. Today 2008, 13:144-151.
8. Attama A.A., Reichl S., Muller-Goymann C.C. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int. J. Pharm. 2008, 355:307-313.
9. Li R., Jiang S., Liu D., Bi X., Wang F., Zhang Q., Xu Q. A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide. J. Microencapsul. 2011, 28:134-141.
10. Pardeike J., Hommoss A., Muller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009, 366:170-184.
11. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik e. V 2004, 58:83-90.
12. Shastri D., Patel L., Parikh R. Studies on in situ hydrogel: a smart way for safe and sustained ocular drug delivery. J. Young Pharm.: JYP 2010, 2:116-120.
13. Ma W.D., Xu H., Wang C., Nie S.F., Pan W.S. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int. J. Pharm. 2008, 350:247-256.
14. Gupta D., Bleakley B., Gupta R.K. Dragon's blood: botany, chemistry and therapeutic uses. J. Ethnopharmacol. 2008, 115:361-380.
15. Silva A.C., Gonzalez-Mira E., Garcia M.L., Egea M.A., Fonseca J., Silva R., Santos D., Souto E.B., Ferreira D. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf. B, Biointerf. 2011, 86:158-165.
16. Schmolka I.R. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 1972, 6:571-582.
17. Gilbert J.C., Richardson J.L., Davies M.C., Palin K.J., Hadgraft J. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J. Controlled Release 1987, 5:113-118.
18. Jeong B., Kim S.W., Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 2002, 54:37-51.
19. Qi H., Li L., Huang C., Li W., Wu C. Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use. Chem. Pharm. Bull. 2006, 54:1500-1507.
20. Vega E., Gamisans F., Garcia M., Chauvet A., Lacoulonche F., Egea M. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J. Pharm. Sci. 2008, 97:5306-5317.
21. Gonzalez-Mira E., Nikolic S., Calpena A.C., Egea M.A., Souto E.B., Garcia M.L. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels. J. Pharm. Sci. 2012, 101:707-725.
22. Barile F.A. Validating and troubleshooting ocular toxicology tests. J. Pharm. Toxicol. Methods 2010, 61:136-145.
23. Kalweit S., Besoke R., Gerner I., Spielmann H. A national validation project of alternative methods to the Draize rabbit eye test. Toxicol. In Vitro: Int. J. Publ. Assoc. BIBRA 1990, 4:702-706.
24. Guo C., Wang J., Liu H.-z., Chen J.-y. Hydration and conformation of temperature-dependent micellization of PEO-PPO-PEO block copolymers in aqueous solutions by FT-Raman. Langmuir 1999, 15:2703-2708.
25. Jeong B., Kim S.W., Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 2012.
26. Mortensen K., Pedersen J.S. Structural study on the micelle formation of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) triblock copolymer in aqueous solution. Macromolecules 1993, 26:805-812.
27. Nikolic S., Keck C.M., Anselmi C., Muller R.H. Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters. Int. J. Pharm. 2011, 414:276-284.
28. Saettone M.F., Chetoni P., Cerbai R., Mazzanti G., Braghiroli L. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int. J. Pharm. 1996, 142:103-113.
29. Kishore A., Surekha P., Sekhar P., Srinivas A., Murthy P.B. Hen egg chorioallantoic membrane bioassay: an in vitro alternative to draize eye irritation test for pesticide screening. Int. J. Toxicol. 2008, 27:449-453.
30. Dholakiya S.L., Barile F.A. Alternative methods for ocular toxicology testing: validation, applications and troubleshooting. Expert Opin. Drug Metab. Toxicol. 2013, 1-14.
31. Abdelkader H., Ismail S., Hussein A., Wu Z., Al-Kassas R., Alany R.G. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. Int. J. Pharm. 2012, 432:1-10.
32. Hughes P.M., Olejnik O., Chang-Lin J.-E., Wilson C.G. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 2005, 57:2010-2032.